Drugs / Pipamperone

Trials 2

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01450514 Mar → Nov 2012 schizoaffective disorder, schizophrenia PharmaNeuroBoost N.V. Completed No outcome recorded
Phase 31 trial
Phase 3 NCT02374567 Jan 2015 → Jun 2017 anxiety disorder, dementia, depressive disorder, schizophrenia +1 Hannover Medical School Terminated No outcome recorded
Comparator or background therapy3 trials
Phase 2 NCT01323205 Background May 2011 → Nov 2012 schizophrenia Janssen Research & Development, LLC Completed No outcome recorded
Phase 2 NCT00672659 Comparator Feb 2008 → Jan 2009 major depressive disorder PharmaNeuroBoost N.V. Completed No outcome recorded
Phase 3 NCT01312922 Comparator Sep 2011 → Nov 2012 major depressive disorder PharmaNeuroBoost N.V. Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Pipamperone ClinicalTrials.gov intervention name — accepted as the source's own label NCT02374567 ↗
3

NCT00672659 ↗

NCT01312922 ↗

NCT01450514 ↗

Known as Floropipamide ChEMBL registry synonym — accepted as the source's own label CHEMBL440294 ↗
Known as NSC-759178 ChEMBL registry synonym — accepted as the source's own label CHEMBL440294 ↗
Known as PIP “This Phase I/IIa Proof-of-Concept (PoC) trial is designed to assess the effect of adding a single and repeated low dose (15mg/d) of pipamperone (PIP) for 6 weeks to stable...” NCT01450514 ↗
1

“Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)” NCT01312922 ↗

Known as Pipamperona ChEMBL registry synonym — accepted as the source's own label CHEMBL440294 ↗
Known as Pipamperone Hydrochloride “Regular antipsychotic medications (Risperidone, Olanzapine, Clozapine, Amisulpride, Quetiapine, Paliperidone, Aripiprazole, Haloperidol, Levomepromazine, Zuclopenthixol...” NCT01323205 ↗
Known as Pipaneperone ChEMBL registry synonym — accepted as the source's own label CHEMBL440294 ↗
Known as R 3345 ChEMBL registry synonym — accepted as the source's own label CHEMBL440294 ↗
Action Inhibit “Pipamperone acts as a highly selective 5-HT2A/D4 antagonist” PMID 21349239 ↗ Feb 2011
Modality Small molecule — CHEMBL440294 ↗
Route Oral “15 mg PIP once daily per os on top of continued stable treatment with RIS or PAL” NCT01450514 ↗